Chemicals
- 806.185
- -6.734-0.83%
Huawei's foldable phone pre-order has exceeded 3 million, and the industry has entered a period of stable growth.
Huawei Mate X Foldable Phone, which was available for pre-order on Huawei Store starting from September 7th, 12:08, has already received over 3 million reservations, reaching 3.137 million people. According to Debang Securities, mainstream smart phone manufacturers have largely completed the layout and iteration of their foldable screen product lines, and the foldable screen phone industry is gradually entering a stable growth period.
Shandong Dongyue Organosilicon Materials' performance has grown against the trend. Will it see improved profits in the second half of the year? | Interpretations.
①In the first half of the year, Shandong Dongyue Organosilicon Materials achieved a revenue of 2.737 billion yuan, a year-on-year growth of 10.21%; net income attributable to shareholders was 65.2173 million yuan, a year-on-year growth of 134.05%; ②Since the beginning of this year, the organosilicon industry has continued to slump, with average prices in the first half of the year falling by about 8% compared to the same period last year. ③Organosilicon is about to enter the traditional peak demand season, coupled with the good overseas demand this year, the profitability of organosilicon companies may improve.
Weak expansion of sales channels? Leading synthetic biology company Huaheng Biological's net profit fell more than 20% in the first half of the year.
Due to increased competition and rising costs, Huaheng Biotech's net income for the first half of the year fell by 21.72%. It is stated that the sales channels for the core product L-Xeonine need to be further expanded, and market share needs to be increased. The registered and effective issuance plan of Huaheng Biotech has been registered and effective, but it is stated that if the project cannot generate benefits as expected or the actual income is lower than expected, there may be a risk of reduced profitability.
The overall weakness of fluorine chemical industry is revealed despite the soaring refrigerant prices. Zhejiang Juhua's Q2 net profit is lower than the peak in the same period of 2022 | Interpretations
① In Q2, zhejiang juhua had a net profit attributable to shareholders of 0.524 billion yuan, which was lower than the same period of 2022; ② The net profit attributable to shareholders in H1 increased by 70.31% year on year, and there is great pressure for profit growth in H2; ③ The refrigerant is outstanding, while other fluorine chemical products are dragging down the performance; ④ The company's diversified layout does not have an advantage in the current stage of the industry.
How promising is the vitamins bull market? Zhejiang Nhu's Q2 net profit of 1.335 billion yuan reached a new high|Interpretation of financial report.
① Vitamins have significantly boosted manufacturers' performance in the bull market; ② Q2 net profit of Zhejiang Nhu reached a new high compared to the same period in history; ③ The company benefits from a high proportion of overseas business; ④ The Q3 increase has widened, further benefiting manufacturers.
Breakthrough in solid state battery technology stimulates rapid development of related industries.
① Penghui Energy's official WeChat announced that a major breakthrough in all-solid-state batteries is coming soon. The 2024 Penghui Energy Product Technology Conference will be held on August 28, and a series of major new products will be released soon. ② CITIC Construction Investment estimates that by 2025, the global market space for various types of solid-state batteries may reach tens to hundreds of GWH or 100 billion yuan.
China's most profitable airline splurges 100 billion.
To create a world-class airline.
90,000, the last defense line of lithium prices? | Jianzhi Research
Has this round of liquidation just begun?
Sichuan Yahua Industrial Group secures another large lithium order with Tesla | Jianzhi Research
Tesla, the largest customer deeply bound to the company, signed a long-term contract for the third time with Sichuan Yahua Industrial Group.
Argus Research Initiates Coverage On Novo Nordisk With Buy Rating, Announces Price Target of $110
Argus Research Maintains Buy on Costco Wholesale, Raises Price Target to $650
Argus Research Reiterates Buy on Amazon.com, Maintains $165 Price Target
Argus Research Reiterates Buy on Booking Holdings, Maintains $3677 Price Target
Argus Research Initiates Coverage On Choice Hotels Intl With Buy Rating, Announces Price Target of $145
Argus Research Downgrades Splunk to Hold
Silk Road Medical Downgraded at Argus on CMS Coverage Decision
Argus Research Maintains Buy on AutoZone, Raises Price Target to $2920
Argus Research Downgrades Silk Road Medical to Hold
Argus Research Upgrades Regency Centers to Buy, Announces $70 Price Target
MSCI Snags Buy Rating at Argus on Slew of Tailwinds